Dysregulation of circulating damage-associated molecular patterns in diabetic foot syndrome
By
Elena Uyy
Viorel-Iulian Suica
Luminita Ivan
Raluca Maria Boteanu
Diana Valentina Uta
Elena Georgiana Bernea
Dragoş Eugen Georgescu
Ovidiu Chiriac
Maya Simionescu
Felicia Antohe
June 22, 2026
Clinical Scorecard: Alterations in Circulating Damage-Associated Molecular Patterns in Patients with Diabetic Foot Syndrome
At a Glance
Category Detail
Condition Diabetic Foot Syndrome Key Mechanisms Chronic inflammation, thrombotic imbalance, impaired wound healing, and systemic alterations in circulating DAMPs. Target Population Patients with type 2 diabetes, including those with varying degrees of limb ischemia. Care Setting Clinical and experimental settings for diabetic foot syndrome management.
Key Highlights
DFS is associated with systemic alterations in circulating DAMP abundance reflecting heightened inflammatory and thrombotic stress. Pharmacological TLR4 inhibition selectively modulates acute-phase DAMPs. DAMPs may serve as candidate molecules for further investigation in DFS. Guideline-Based Recommendations
Diagnosis
Stratify patients according to disease severity using the Wagner-Armstrong classification system. Management
Tailor therapeutic interventions based on the severity of diabetic foot syndrome. Monitoring & Follow-up
Assess inflammatory and hemostatic markers such as C-reactive protein and interleukin 6. Risks
Increased risk of amputation in patients with diabetic foot syndrome compared to those without diabetes. Patient & Prescribing Data
Individuals with type 2 diabetes, particularly those with diabetic foot syndrome.
Limited therapeutic options for promoting ulcer healing in patients not candidates for revascularization.
Clinical Best Practices
Early detection and accurate ulcer classification are crucial for effective management of DFS. Multidisciplinary communication improves comparability of clinical studies. Related Resources & Content
